Ref. 2024-037-01 Bioinformatician for the Computational Immunogenomics Group

The Vall d´Hebron Institute of Oncology (VHIO) Seeks a “Cancer Genomics Bioinformatician”

Reference: Ref. 2024-037-01

Application deadline: 17/06/2024

Number of vacancies: 1

Job description:

The Computational Immunogenomics group, led by Francisco Martínez-Jiménez, is currently searching for a dynamic and driven bioinformatician to join our team. This opportunity involves engaging in diverse projects aimed at unraveling the genomic underpinnings of tumorigenesis and its intricate interactions with the immune system.

The candidate will play an integral role in our translational research projects, actively contributing to the development of data-driven applications that directly impact clinical practice. Her/his involvement will encompass curating, organizing, and effectively analyzing extensive cancer genomics and transcriptomics datasets of patients treated with cancer immunotherapies.


Efficiently process and analyze internal and external cancer genomics (WES/WGS) and transcriptomics data from patients treated with immune checkpoint blockade.
Identification of composite biomarkers of upfront immunotherapy resistance.
Prepare reports to be shared with clinical collaborators.

Degree in bioinformatics, computer science, biological sciences or similar.
Experience of at least 6 months.
Strong knowledge of Unix operating systems
Fluent in Python/R and in Bash scripting
Excellent organization skills.
Knowledge of processing and analyzing cancer genomics data (WGS/WES).
Team player.
Good English communication skills.

Additional information:


Experience with Nextflow and/or Snakemake pipelines.
Experience with Google Cloud Platform and/or Amazon Web Services.
Experience with transcriptomics and single-cell RNA-seq data.

Full-time position: 40h/week
Starting date: 1st July of 2024
Gross annual salary will depend on experience and skills. and always guaranteeing the minimum remuneration established in the VHIO collective agreement for each professional category.
Contract: permanent linked to project, to carry out scientific and technical activities.
What can we offer?

Incorporation to Vall d’Hebron Institute of Oncology (VHIO).
Continuous learning and a wide range of responsibilities within a stimulating work environment.
Personal training opportunities.
Flexible working hours.
Teleworking (part-time) according to VHIOs collective agreement
23 days of holidays + 5 personal days
Flexible Remuneration Program (including dining checks, health insurance, transportation and more)
Access to VHIO’s personal development and training plan.
Being part of a center that is constantly developing, highly competitive, seeking excellence in research and collaborating with leading teams.
We offer and promote a diverse and inclusive environment and welcome all people equally, regardless of age, disability, gender, nationality, race, religion, or sexual orientation.
For recent and relevant publications, you may check: and

The vacancy will be available until the position is filled.


Applicants should send a full Curriculum Vitae and a cover letter to including the reference “Ref. 2024-037-01” in the subject line of your email. Please also attach a minimum of two referee (s) contact to your application.

Review of applications will commence immediately.

About VHIO:

Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), has established itself as a comprehensive cancer center of proven excellence internationally. It is also thanks to VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.

Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.

VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.

VHIO’s translation toward precision oncology: